top of page

Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Thursday, October 4th, 2018

6:00pm ~ Registration and dinner

6:30pm - 7:45pm ~ Education Program

*Buffet Dinner will be provided*

Maggiano's Little Italy at Park Square

4 Columbus Avenue

Boston, MA 02116

Capri-Medici Room

Hosted by

Boston Oncology Nursing Society Chapter


This 1.25-hour session will include 5 topic modules focused on the management of ER-positive mBC. Each module will employ an identical format and feature discussion of cases from the faculty members selected to depict common scenarios encountered in clinical practice (newly diagnosed ER-positive mBC, disease progression on an adjuvant aromatase inhibitor, progression on CDK4/6 inhibitor with endocrine therapy, et cetera). Topics addressed during the session will include the following:

~ Module 1 ~ Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment

~ Module 2 ~ First-Line Endocrine Therapy for Metastatic Disease: Role of CDK4/6 Inhibitors

~ Module 3 ~ Second-Line Endocrine Therapy for Metastatic Disease: Role of mTOR Inhibitors

~ Module 4 ~ New Approaches Under Investigation

~ Module 5 ~ Assessing and Optimizing Treatment Adherence

38 views0 comments

Recent Posts

See All

Cancer Equity Colloquium 2024

Now more than ever, the presence of social inequities in healthcare is evident. This two-day, hybrid event, the Cancer Equity Colloquium, will address the diverse issues that underlie cancer inequitie


bottom of page